MTOR and head and neck squamous cell carcinoma: In addition, mTOR inhibition by rapamycin has been shown to prevent early onset of HNSCC tumorigenesis in both the 4NQO-induced HNSCC mouse model [116] and a HNSCC-GEMM [117].